Exercise Medicine for Clinical Oncology - A Hard Pill to Swallow
Displaying until April 23, 2025
Thursday, April 24 from 11:10-12:00 at 007-0001 (ATL). Dr. Dieli-Conwright, a Cal Poly alumna located at Harvard Medical School and the Dana-Farber Cancer Institute, is an exercise oncology researcher who examines the effects of post-diagnosis exercise on cancer prognosis with a specific focus on biomarkers related to body composition, inflammation, cognition, and metabolic dysregulation. This seminar will discuss Dr. Dieli-Conwright’s journey through academic research thus far, with an evaluation of the importance of exercise medicine for cancer survivors.